RSS Feed Creator Pro (Unlicensed) 23 Aug 2010 11:18:36 GMT WSNS News The latest neuroglogy news in Washington State. http://www.washingtonneurology.org/ http://blogs.law.harvard.edu/tech/rss FDA Safety Communication: Chronic Cerebrospinal Venous Insufficiency Treatment in Multiple Sclerosis Patients The FDA is alerting people with MS to the risks of serious injuries and death associated with procedures to treat chronic cerebrospinal venous insufficiency (CCSVI). Furthermore, the benefits of these experimental procedures have not been proven, and their promotion as a treatment for MS may lead people with the disease to make treatment decisions without being aware of the serious risks involved. Wed, 16 May 2012 13:00:00 GMT http://www.washingtonneurology.org/ http://www.washingtonneurology.org/index.htm#news3 Neurological Complications of New Melanoma Drug Ipilimumab Imilimumab (YERVOY) is a new monoclonal antibody used in the treatment of melanoma. It can result in severe and fatal immune-mediated adverse reactions due to T-cell activation and proliferation. Mon, 26 March 2012 13:00:00 GMT http://www.washingtonneurology.org/ http://www.washingtonneurology.org/2 Tysabri (natalizumab): New Risk Factor for PML ISSUE: FDA notified healthcare profesisonals that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoencephalopathy (PML). PML is a rare but serious brain infection associated with use of Tysabri (natalizumab) for the treatment of multiple sclerosis (MS) or Crohn's disease. <a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm288602.htm">More</a>(01/24/12) Mon, 23 Jan 2012 13:00:00 GMT http://www.washingtonneurology.org/ http://www.washingtonneurology.org/